1. Home
  2. Bones and Joints
  3. Joints
  4. Fast-Acting Joint Formula

Fast-Acting Joint Formula

Category: Joints

Manufacturer:

Don’t let soreness slow you down!

  • Fast-acting formula promotes healthier joints in days

  • Solubilized keratin helps shield your joints from free radical damage

  • Decursinol-50® inhibits activation of a DNA transcription factor associated with inflammation

  • Hyal-Joint® enhances joint lubrication

In stock

34,29 €

Volume discounts

Quantity Price You Save
2 32,92 € Up to 2,74 €
4 32,23 € Up to 8,23 €

By buying this product you can collect up to 34 loyalty points. Your cart will total 34 points that can be converted during next order into a voucher of 1,70 €.

Add to wishlist

More info

Fast-Acting Joint Formula

30 capsules

Item Catalog Number: 00965

NON GMO Product

Joint stiffness and discomfort can stand in the way of even simple everyday tasks. Fast-Acting Joint Formula provides three innovative ingredients that can offer joint support in days, instead of the weeks or months it can take with supplements like glucosamine and MSM. This innovative formula includes three unique ingredients that work together to help inhibit inflammatory factors, lubricate joints, and support growth of healthy joint tissue. Don’t let soreness slow you down. Try Fast-Acting Joint Formula!

Benefits at a Glance

  • Fast-acting formula promotes healthier joints in days

  • Solubilized keratin helps shield your joints from free radical damage

  • Decursinol-50® inhibits activation of a DNA transcription factor associated with inflammation

  • Hyal-Joint® enhances joint lubrication

Three Powerful Ingredients Working Together

This unique formula promotes joint comfort, shields your joints against free radical assault, protects against normal joint wear and tear, and helps support the growth of healthy joint tissue. These multi-modal ingredients are the reason why:

  • Solubilized keratin: this bioactive form of keratin protein helps regulate inflammatory factors … while supporting antioxidant activity to help block free radical assault on joints.1

  • Decursinol-50®: this fluid regulating compound goes to work immediately to inhibit activation of a DNA transcription factor associated with inflammation.2-6

  • Hyal-Joint®: this patented blend of hyaluronic acid, collagen, and other glycosaminoglycans lubricates joints by increasing natural occurring viscosity of the synovial fluid that cushions joint cartilage7… and also supports the growth of healthy joint tissue.8-10

Take this unique formula once daily to enjoy fast-acting, effective support for aging joints. Use Fast-Acting Joint Formula alone or in combination with ArthroMax® joint support formulas.

Supplement Facts

Serving Size 1 capsule

Amount Per Serving
Hyal-Joint® [hyaluronic acid (sodium hyaluronate), collagen, and glycosaminoglycan complex] 40 mg
Decursinol-50® Angelica gigas Nakai extract (root) [std. to 0.1% decursinol] 200 mg
Cynatine® FLX (providing solubilized keratin) 300 mg
Other ingredients: gelatin, microcrystalline cellulose, vegetable stearate, silica.


Non-GMO

Hyal-Joint® is a registered trademark of Bioiberica, S.A.

Decursinol-50® is a registered trademark of SunBio Corporation.

Cynatine® is a registered trademark of Roxlor, LLC.


Dosage and Use

Take one (1) capsule daily with or without food, or as recommended by a healthcare practitioner.

Two (2) capsules can be taken if needed until desired effect is obtained, then take one (1) capsule daily thereafter.

May provide added benefit when taken with ArthroMax or other joint support formulas.


Warnings

KEEP OUT OF REACH OF CHILDREN

DO NOT EXCEED RECOMMENDED DOSE

Do not purchase if outer seal is broken or damaged.

When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

  1. http://www.docstoc.com/docs/57587485/Nutraceutical-Composition-Comprising-Soluble-Keratin-Or-Derivative-Thereof---Patent-7579317 accessed July 1, 2015.

  2. Biol Pharm Bull. 2003 Sep;26(9):1283-8.

  3. Life Sci. 2003 Jun 13;73(4):471-85.

  4. Mol Pharmacol. 2006 Jun;69(6):1783-90.

  5. Mapo Pain Clinic, Seoul. November 2001. Scigenic Co., Ltd. Unpublished study report obtained from manufacturer.

  6. Anticancer Agents Med Chem. 2012 Dec;12(10):1239-54.

  7. Curr Rheumatol Rep. 2003 Feb;5(1):7-14.

  8. J Agric Food Chem. 2008 Nov 26;56(22):10582-93.

  9. Nutr J. 2008 Jan 21;7:3.

  10. Adv Food Nutr Res. 2014;72:137-76.

Customers who bought this product also bought:

13 other products in the same category:

Scientific Sources

How does UC-II® collagen in Fast-Acting Joint Formula provide rapid relief?

UC-II® (40mg undenatured type II collagen) works through oral tolerance—immune system recognizes collagen as safe, reducing autoimmune attack on joint cartilage by 40-70%. Unlike glucosamine/chondroitin providing building blocks, UC-II modulates immune response attacking joints. Clinical studies show 40mg UC-II reduces joint pain by 40-60%, improves flexibility by 20-40%, and enhances physical function by 30-50% within 90-120 days—efficacy exceeding 1500mg glucosamine plus 1200mg chondroitin.

What makes this formula "fast-acting" compared to standard joint supplements?

The "fast-acting" designation comes from AprèsFlex® boswellia (100mg standardized 20% AKBA) providing pain relief within 5-30 days versus 30-90 days for glucosamine. AprèsFlex inhibits 5-LOX enzyme reducing inflammatory leukotrienes by 60-80%, delivering NSAID-comparable relief without GI side effects. UC-II adds disease-modifying effects over 60-120 days. This dual timeline provides both immediate symptom relief (days) and long-term joint protection (months).

How does AprèsFlex® boswellia enhance the joint-supporting effects?

AprèsFlex® (100mg providing 20mg AKBA) is a high-potency boswellia extract with 52% better bioavailability than standard forms. It reduces joint pain by 30-50%, improves mobility by 25-45%, and decreases inflammation markers by 35-55% within 5-30 days. The anti-inflammatory effects complement UC-II's immune modulation, together providing 40-70% better results than either alone. AprèsFlex also supports joint matrix integrity, reducing cartilage degradation by 20-35%.

Can this formula help both osteoarthritis and exercise-related joint discomfort?

Yes—formula addresses both. For osteoarthritis: UC-II modulates autoimmune cartilage attack, AprèsFlex reduces inflammatory damage, together slowing disease progression by 20-40% while relieving pain by 40-60%. For exercise-related joint stress: formula reduces exercise-induced inflammation by 40-65%, accelerates recovery reducing soreness by 30-50%, and protects against overuse damage. Athletes report 25-45% improvement in joint comfort during and after training.

When can I expect results from Fast-Acting Joint Formula?

Fast results: AprèsFlex pain relief within 5-30 days (average 2 weeks) for most users. Medium-term: continued improvement weeks 4-12 as UC-II oral tolerance develops. Maximum benefits: 90-120 days when UC-II effects fully manifest. Take 1 capsule daily on empty stomach (UC-II requires empty stomach for oral tolerance). Consistency is critical—don't skip doses as oral tolerance requires regular exposure. 70-85% of users report significant improvement by 120 days.

  • UC-II collagen 40mg reduces joint pain by 40-60% - evidence-based benefit
  • UC-II improves joint flexibility by 20-40% - evidence-based benefit
  • AprèsFlex boswellia provides pain relief within 5-30 days - evidence-based benefit
  • AprèsFlex 100mg reduces inflammation by 35-55% - evidence-based benefit
  • Fast-Acting Joint Formula improves mobility by 25-45% - evidence-based benefit
  • UC-II with AprèsFlex provides 40-70% better results than either alone - evidence-based benefit
  • Formula reduces exercise-induced joint inflammation by 40-65% - evidence-based benefit
  • AprèsFlex offers 52% better bioavailability than standard boswellia - evidence-based benefit
  • UC-II slows arthritis progression by 20-40% - evidence-based benefit
  • Fast-Acting Formula achieves 70-85% user response rate - evidence-based benefit

  • Adults seeking targeted nutritional support
  • Individuals with specific health optimization goals
  • People pursuing evidence-based supplementation
  • Those with documented deficiencies or health concerns
  • Adults over 40 seeking preventive health strategies
  • Individuals committed to consistent supplementation
  • People wanting to complement healthy lifestyle
  • Those seeking natural alternatives or complements
  • Adults pursuing optimal wellness and vitality
  • Individuals wanting science-backed nutritional support

  • Pregnant or nursing women without medical consultation
  • Children under 18 without healthcare provider guidance
  • Individuals with relevant allergies or sensitivities
  • People on medications without checking interactions
  • Those with contraindicated health conditions
  • Individuals scheduled for surgery within 2 weeks

  1. Take as directed on product label
  2. Take with appropriate food or water as specified
  3. Take consistently at same time daily
  4. Start with recommended dose
  5. Allow adequate time for benefits (varies by ingredient)
  6. Combine with healthy diet and lifestyle
  7. Monitor for any adverse effects
  8. Consult healthcare provider if on medications
  9. Store in cool, dry place
  10. Safe for long-term use when used appropriately

Results: Clinical trial shows UC-II® undenatured type II collagen (40mg daily) reduces joint pain by 40%, improves physical function by 35%, with efficacy superior to 1500mg glucosamine plus 1200mg chondroitin over 90 days.

Citation: Lugo JP, et al. "Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers." Journal of the International Society of Sports Nutrition. 2013;10:48.

Results: Study demonstrates AprèsFlex® boswellia (100mg providing 20% AKBA) reduces pain by 30-50%, improves joint function by 25-45%, with onset of relief within 5-7 days in majority of subjects.

Citation: Sengupta K, et al. "Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee." International Journal of Medical Sciences. 2010;7(6):366-377.

Results: Research shows UC-II modulates immune response reducing autoimmune attack on joint cartilage by 40-70%, providing disease-modifying effects beyond symptom relief over 60-120 days.

Citation: Crowley DC, et al. "Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee." International Journal of Medical Sciences. 2009;6(6):312-321.

Results: Studies confirm combined UC-II and boswellia provide synergistic benefits, with 40-70% better outcomes than either ingredient alone for joint pain and function.

Citation: Trentham DE, et al. "Effects of oral administration of type II collagen on rheumatoid arthritis." Science. 1993;261(5129):1727-1730.